The initial public offering (IPO) of Rubicon Research kicks-off for bidding on Thursday, October 09 and will close for bidding on Monday, October 13. The pharmaceuticals player is offering its shares in the range of Rs 461-485 apiece and investors can apply for a minimum of 30 equity shares and its multiples thereafter. Advertisement

Rubicon Research is looking to raise a total of Rs 1,377.50 crore via IPO, which includes a fresh share sale of Rs 500 crore and an offer-for-sale (OFS) of up to 1,80,92,762 equity shares worth Rs 877.50 crore. The net proceeds from the issue shall be utilized towards prepayment or repayment of debt; funding inorganic growth; and general corporate purposes.

Incorporated in 1999, Thane-based Rubicon Research is a pharmaceutical company engaged in the develop

See Full Page